Login Form
Webcasts
Note: to view these webcasts you need to be a registered userWorld Cord Blood Congress III, Roma, Italy, October 2011
ESH - EBMT Training Course Blood and Marrow Transplantation, La Baule, France, May 2011
ESTM Cord Blood Banking Conference, Pescara, Italy, November 2009
ESH-EBMT Training Course, Latimer, UK, May 2009
ESH-Eurocord-Netcord Cord Blood Conference, Mandelieu, France, October 2008
Social media
Subscribe to news alert
This site complies with the HONcode standard for trustworthy health information:
verify here.
EUROCORD-ED is the European Online Cord Blood Learning Portal for use by Doctors, Nurses, Midwives, Surgeons, UCB Processing & Testing Laboratories, Scientists and Study Groups.
Upcoming Events
ESH-iCMLf International Conference CHRONIC MYELOID LEUKEMIA: Biology and Therapy
Speakers at this meeting will present the newest and often unpublished data that relate to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) Aspects of treatment including prediction and definition of responses, drugs used in combination, molecular monitoring, targeting residual stem cells and approaches to cure.
Direct link
ESH International Conference on Myeloproliferative Neoplasms
Over the past few years there has continued to be a flood of new insights into the classification, pathogenesis and management of the myeloproliferative neoplasms. This event is essentially a workshop with an audience. It brings together scientists and clinicians with new data on the cellular and molecular biology of these disorders as well as their diagnosis and treatment
Direct link
ESH International Conference on Lymphomas
Our knowledge on the pathology of lymphoma and on the therapeutic possibilities has greatly changed during the last 10 years. Lymphoma is a complex cancer with several entities, each with its own genetic abnormalities, spreading characteristics, and therapeutic options.
Numerous pathways controlling important cellular mechanisms have been found to be deregulated in lymphoma cells, leading to cell growth or refractoriness to therapy. Inhibitors specific for these different pathways are gaining therapeutic roles.
Direct link
|
|||||||


Webcasts

PDF
